I really didn't see the death of short-acting beta-agonists (SABAs) coming. Sure, I'd read the SYGMA trials, [1,2] and yes, I was aware of lobbying from the "other side of the pond" (Europe).

And they're called Generation Beta. Generation Beta, or Gen Beta for short, will be born from 2025 to 2039, according to Australian trends and demographic analysis company McCrindle, which also ...